[ad_1]
A Rosenblatt analyst sees Apple deviating from the path on artificial intelligence in at least two ways — both of which he says could help the consumer-electronics stock.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...